# Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity

> **NCT00339014** · PHASE2 · COMPLETED · sponsor: **Orexigen Therapeutics, Inc** · enrollment: 611 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Zonisamide CR and Bupropion SR
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00339014
- **Lead sponsor:** Orexigen Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 611 (ACTUAL)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00339014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00339014, "Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00339014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*